Market View 12th May 2023

View on market: Stay Cautious, be with quality business:

Stocks in Asia are set for a muted open after a mixed U.S. session that saw treasuries and the dollar rally on signals of a cooling jobs market and renewed concerns about the health of regional lenders. Equity futures in Hong Kong advanced, while those for Japan and Australia were little changed and U.S. contracts were stable in early Asian trade. The S&P 500 slid 0.2% on Thursday following jobs and inflation data, while the tech-heavy Nasdaq 100 added 0.3% after Google parent Alphabet Inc. showcased its artificial intelligence tools. Data showed U.S. initial jobless claims reached the highest since October 2021 while producer prices rose 0.2% in April, trailing economists’ estimates for a 0.3% increase. Meanwhile, the yield on 10-year treasuries in U.S. was trading at 3.38%. Crude prices fell over 1% below $75-mark, while Bitcoin declined to 27,000-level. At 5:20 a.m., the Singapore-traded SGX Nifty, an early indicator of the Nifty 50 Index’s performance in India, was down 0.34% at 18,287.5. Index provider MSCI Inc. added three India stocks to its emerging markets index on Friday as part of its May review. Defence manufacturer Hindustan Aeronautics, hospital chain operator Max Healthcare Institute and auto components maker Sona BLW Precision Forgings were added to the index under the quarterly rejig, a statement from the index provider showed. Notably, Max Healthcare has been upgraded

Economic Calendar:

• USD : Retail Sales (MoM) (Apr) on 13^th May, 2023
• USD : Building Permits (Apr) on 17^th May, 2023
• INR : CPI (YoY) (Apr) on 12^th May, 2023
• INR : Industrial Production (YoY) (Mar) on 12^th May, 2023

Q4 Results Today: Tata Motors, Hindustan Petroleum Corporation, Hindustan Aeronautics, Cipla, Polycab India, Indraprastha Gas, Sharda Cropchem, Colgate-Palmolive (India), Manappuram Finance, Kirloskar Ferrous Industries, Laxmi Organic Industries, Greaves Cotton, Sapphire Foods India, Solara Active Pharma Sciences, VST Tillers Tractors, Butterfly Gandhimathi Appliances

Brokerage Radar:

JEFFERIES ON EICHER MOTORS: Buy, TP Rs 4000; 4Q EBITDA rose 23% YoY (5% above JEFe) to a new high.  RE volumes grew 18% YoY while EBITDA/vehicle rose 12% QoQ.  Despite ongoing 2W downturn, EIM delivered highest RE volumes and EPS in FY23

NOMURA ON HNDALCO: Buy, TP Rs 540; Novelis 4Q: profitability weak led by weak can demand, in line with est. Beverage can demand could continue to be weak; Novelis’management has guided for destocking to continue in 1QFY24 as well

MS ON ASIAN PAINTS: UW, TP Rs 2546; 4Q earnings positively surprised us and consensus on margins. Management has called out that they will aggressively pursue growth going ahead. Management has retained its 18-20% EBITDA margin guidance. Co may consider taking price cuts if needed

International Markets

U.S & Europe:

Asian markets

ADR Watch:

Commodities & Currency

FIIs & DIIs:

News Update:

ONGC: The company said it has discovered oil and gas reserves in Amrit and Moonga exploration blocks in Mumbai Offshore on the Arabian Sea. Detailed assessment of the discoveries is in progress.

Mahindra & Mahindra: The auto major reported a 18.54% jump year-on-year in production volumes during April at 58,644 units, whereas sales increased 40.86% to 60,481 units compared to the corresponding months of last year. Exports slumped 32.93% in annual terms to 1,813 units.

GMR Airports Infrastructure: Passenger traffic at five airports managed by the company increased 33% year-on-year to 97.67 lakh during April. Meanwhile, aircraft movement at these airports saw 22% rise to 64,600 during last month.

Reliance Industries/Bharti Airtel/Vodafone Idea: As per TRAI data, Reliance Jio added 10.05 lakh subscribers, while Bharti Airtel gained 9.83 lakh users in February. Meanwhile, Vodafone Idea lost 10.26 lakh subscribers during the month under review.

NBCC (India): The company received total business of Rs 1,264.48 crore in April.

HDFC Bank: The Mumbai bench of NCLT admitted insolvency plea by HDFC Bank against Eurolife Healthcare over a default of Rs 45.11 crore.

IPCA Laboratories: The Mumbai bench of NCLT approved the merger of Ramdev and Tonira Exports with the company.

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from pMarket View 13th April 2023reviously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL